2118 related articles for article (PubMed ID: 33563817)
1. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis.
Ng WH; Tipih T; Makoah NA; Vermeulen JG; Goedhals D; Sempa JB; Burt FJ; Taylor A; Mahalingam S
mBio; 2021 Feb; 12(1):. PubMed ID: 33563817
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
5. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and comorbidities: a systematic review and meta-analysis.
Gold MS; Sehayek D; Gabrielli S; Zhang X; McCusker C; Ben-Shoshan M
Postgrad Med; 2020 Nov; 132(8):749-755. PubMed ID: 32573311
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis.
Choi JH; Choi SH; Yun KW
J Korean Med Sci; 2022 Feb; 37(5):e35. PubMed ID: 35132841
[TBL] [Abstract][Full Text] [Related]
8. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
[TBL] [Abstract][Full Text] [Related]
9. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
Dessie ZG; Zewotir T
BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
[TBL] [Abstract][Full Text] [Related]
10. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
11. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis.
Kaur H; Thakur JS; Paika R; Advani SM
Asian Pac J Cancer Prev; 2021 May; 22(5):1333-1349. PubMed ID: 34048161
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
13. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
14. Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
Lunski MJ; Burton J; Tawagi K; Maslov D; Simenson V; Barr D; Yuan H; Johnson D; Matrana M; Cole J; Larned Z; Moore B
Cancer; 2021 Jan; 127(2):266-274. PubMed ID: 33112411
[TBL] [Abstract][Full Text] [Related]
15. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis.
Gabbai-Armelin PR; de Oliveira AB; Ferrisse TM; Sales LS; Barbosa ERO; Miranda ML; Salomão KB; Brighenti FL
Eur J Clin Invest; 2021 Jun; 51(6):e13559. PubMed ID: 33772772
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis.
Espinosa OA; Zanetti ADS; Antunes EF; Longhi FG; Matos TA; Battaglini PF
Rev Inst Med Trop Sao Paulo; 2020; 62():e43. PubMed ID: 32578683
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.
Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H
Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
